From April 1, 2024 to June 30, 2024, the company has repurchased 1,055,600 shares, representing 0.31% for CNY 15.17 million. With this, the company has completed the repurchase of 2,504,800 shares, for CNY 40.58 million under the buyback announced on November 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.41 CNY | -1.47% | -4.76% | -40.79% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-40.79% | 645M | |
-5.17% | 6.92B | |
+21.62% | 3.6B | |
-3.20% | 3.03B | |
+13.01% | 1.64B | |
-9.18% | 1.19B | |
-34.91% | 1.1B | |
-36.76% | 1.05B | |
-32.83% | 895M | |
-17.45% | 872M |
- Stock Market
- Equities
- 603566 Stock
- News Pulike Biological Engineering, Inc.
- Tranche Update on Pulike Biological Engineering, Inc.'s Equity Buyback Plan announced on November 14, 2023.